Testing effectiveness (Phase 2)Study completedNCT03089606
What this trial is testing
Pembrolizumab TX-naive Distant Mets Melanoma and Use of (C11-AMT) PET at Baseline as Imaging Biomarker
Who this might be right for
Melanoma
UNC Lineberger Comprehensive Cancer Center 27